P. Venner
Impact in
- Oncology top 2%
- Bone health and treatments
- Cancer Diagnosis and Treatment
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in ⓘ
-
- Prostate Cancer Treatment and Research 11
- Prostate Cancer Diagnosis and Treatment 2
- Oncology 5
- Bone health and treatments 4
- Cancer Diagnosis and Treatment 2
- Pancreatic and Hepatic Oncology Research 1
- Co-authors
- Louis Lacombe (4 shared papers)Donald M. Gleason (4 shared papers)Robin Murray (4 shared papers)Joseph L. Chin (3 shared papers)Fred Saad (3 shared papers)J. A. Goas (1 shared paper)Nicholas J. Vogelzang (2 shared papers)Paul F. Schellhammer (2 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)JNCI Journal of the National Cancer Institute (1 paper)The Journal of Urology (1 paper)European Urology (1 paper)Annals of Oncology (1 paper)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
P. Venner
12 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 65
- Oncology 1.1k
- Pulmonary and Respiratory Medicine 887
- Orthopedics and Sports Medicine 209
- Radiology, Nuclear Medicine and Imaging 520
- Cancer Research 107
Countries citing papers authored by P. Venner
This map shows the geographic impact of P. Venner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Venner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Venner more than expected).
Fields of papers citing papers by P. Venner
This network shows the impact of papers produced by P. Venner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Venner. The network helps show where P. Venner may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Venner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma Hit paper breakdown → | 2002 | 1242 |
| 2 | 2012 | 32 | |
| 3 | 1996 | 20 | |
| 4 | 2010 | 20 | |
| 5 | 2004 | 10 | |
| 6 | 2004 | 6 | |
| 7 | 2004 | 5 | |
| 8 | 1987 | 4 | |
| 9 | 2014 | 3 | |
| 10 | 1987 | 3 | |
| 11 | Cost-effectiveness analysis of metformin with enzalutamide in the metastatic castrate-resistant prostate cancer setting. | 2019 | 2 |
| 12 | 1992 | 1 |
About P. Venner
P. Venner is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Endocrinology, Diabetes and Metabolism and Genetics, having authored 12 papers that have together received 1.3k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (11 papers), Bone health and treatments (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Cancer Diagnosis and Treatment (2 papers), Estrogen and related hormone effects (2 papers), Prostate Cancer Diagnosis and Treatment (2 papers), Hormonal and reproductive studies (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Oncology (1.1k citations), Pulmonary and Respiratory Medicine (887 citations), Orthopedics and Sports Medicine (209 citations), Radiology, Nuclear Medicine and Imaging (520 citations) and Cancer Research (107 citations). P. Venner has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Louis Lacombe, Donald M. Gleason, Robin Murray, Joseph L. Chin, Fred Saad, J. A. Goas, Nicholas J. Vogelzang, Paul F. Schellhammer, Michael Sarosdy and Jason M. Jones. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute, The Journal of Urology, European Urology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.